blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3750915

EP3750915 - NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2023
Database last updated on 30.10.2024
FormerThe patent has been granted
Status updated on  08.04.2022
FormerGrant of patent is intended
Status updated on  24.11.2021
FormerRequest for examination was made
Status updated on  18.06.2021
FormerThe application has been published
Status updated on  13.11.2020
Most recent event   Tooltip24.03.2023Lapse of the patent in a contracting state
New state(s): AL
published on 26.04.2023  [2023/17]
Applicant(s)For all designated states
UCB Biopharma SRL
Allée de la Recherche 60
1070 Brussels / BE
[2020/51]
Inventor(s)01 / FINNEY, Helene Margaret
IPD, UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
02 / RAPECKI, Stephen Edward
IPD, UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
03 / WRIGHT, Michael John
IPD, UCB Celltech
208 Bath Road
Slough, Berkshire SL1 3WE / GB
 [2020/51]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[2022/19]
Former [2020/51]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date20176103.828.05.2015
[2020/51]
Priority number, dateGB2014000955829.05.2014         Original published format: GB 201409558
[2020/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3750915
Date:16.12.2020
Language:EN
[2020/51]
Type: B1 Patent specification 
No.:EP3750915
Date:11.05.2022
Language:EN
[2022/19]
Search report(s)(Supplementary) European search report - dispatched on:EP13.11.2020
ClassificationIPC:C07K16/00, C07K16/14, C07K14/39, C07K16/46
[2020/51]
CPC:
G01N33/6854 (EP,IL,KR,US); C07K16/28 (IL,US); C07K16/00 (EP,CN,IL,KR,US);
C07K16/14 (EP,CN,IL,US); C07K16/468 (EP,CN,IL,US); G01N33/536 (EP,IL);
C07K2317/31 (IL,KR,US); C07K2317/55 (IL,KR,US); C07K2317/622 (IL,KR,US);
C07K2317/76 (IL,US); C07K2317/92 (IL,KR,US); C07K2319/00 (EP,CN,IL,KR,US);
C07K2319/21 (EP,IL); C07K2319/73 (EP,IL) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/29]
Former [2020/51]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA16.06.2021
ME16.06.2021
Validation statesMA16.06.2021
TitleGerman:NEUES BISPEZIFISCHES FORMAT ZUR VERWENDUNG BEI HOCHDURCHSATZSCREENING[2020/51]
English:NEW BISPECIFIC FORMAT SUITABLE FOR USE IN HIGH-THROUGH-PUT SCREENING[2020/51]
French:NOUVEAU FORMAT BISPÉCIFIQUE APPROPRIÉ POUR UNE UTILISATION DANS LE CRIBLAGE TRÈS HAUT DÉBIT[2020/51]
Examination procedure10.06.2021Amendment by applicant (claims and/or description)
16.06.2021Examination requested  [2021/29]
16.06.2021Date on which the examining division has become responsible
25.11.2021Communication of intention to grant the patent
04.04.2022Fee for grant paid
04.04.2022Fee for publishing/printing paid
04.04.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15726923.4  / EP3149032
Opposition(s)14.02.2023No opposition filed within time limit [2023/16]
Fees paidRenewal fee
22.09.2020Renewal fee patent year 03
22.09.2020Renewal fee patent year 04
22.09.2020Renewal fee patent year 05
22.09.2020Renewal fee patent year 06
31.05.2021Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL11.05.2022
MC11.05.2022
RS11.05.2022
SM11.05.2022
[2023/17]
Former [2023/11]MC11.05.2022
RS11.05.2022
SM11.05.2022
Former [2023/10]RS11.05.2022
SM11.05.2022
Former [2022/50]RS11.05.2022
Documents cited:Search[A]WO9311162  (PROTEIN DESIGN LABS INC [US]) [A] 1-6 * page 25 - page 27; figure 5 *;
 [A]WO2004081051  (UNIV BIRMINGHAM [GB], et al) [A] 1-6 * the whole document *;
 [A]WO2014001326  (HOFFMANN LA ROCHE [CH], et al) [A] 1-6 * page 6 - page 7 * * example 13; claims 1,16 *;
 [A]  - D. M. GOLDENBERG ET AL, "Multifunctional Antibodies by the Dock-and-Lock Method for Improved Cancer Imaging and Therapy by Pretargeting", THE JOURNAL OF NUCLEAR MEDICINE, (20080101), vol. 49, no. 1, doi:10.2967/jnumed.107.046185, ISSN 0161-5505, pages 158 - 163, XP055028152 [A] 1-6 * page 159 * * pages 1,2 *

DOI:   http://dx.doi.org/10.2967/jnumed.107.046185
 [A]  - ROLAND KONTERMANN, "Dual targeting strategies with bispecific antibodies", MABS, LANDES BIOSCIENCE, US, (20120301), vol. 4, no. 2, doi:10.4161/MABS.4.2.19000, ISSN 1942-0870, pages 182 - 197, XP009160769 [A] 1-6 * the whole document *

DOI:   http://dx.doi.org/10.4161/mabs.4.2.19000
Examination   - B. J. Wranik ET AL, "LUZ-Y, a Novel Platform for the Mammalian Cell Production of Full-length IgG-bispecific Antibodies", Journal of Biological Chemistry, (20121101), vol. 287, no. 52, doi:10.1074/jbc.M112.397869, ISSN 0021-9258, pages 43331 - 43339, XP055204058

DOI:   http://dx.doi.org/10.1074/jbc.M112.397869
by applicantWO9222853
 US5731168
 WO9820734
 WO2005003169
 WO2005003170
 WO2005003171
 WO2005113605
 US7183076
 WO2009040562
 WO2010035012
 EP1570267
 WO2014001326
    - D. HOLMES, Nature Rev Drug Disc, (20111100), vol. 10, page 798
    - RIDGWAY et al., Protein Eng., (19960000), vol. 9, pages 617 - 621
    - MERCHANT et al., Nat. Biotechnol., (19980000), vol. 16, no. 7, pages 677 - 81
    - HOLLIGERHUDSON, Nature Biotech., (20050000), vol. 23, no. 9, pages 1126 - 1136
    - ADAIRLAWSON, Drug Design Reviews - Online, (20050000), vol. 2, no. 3, pages 209 - 217
    - VERMA et al., Journal of Immunological Methods, (19980000), vol. 216, pages 165 - 181
    - YANG et al., J. Mol. Biol., (19950000), vol. 254, pages 392 - 403
    - MARKS et al., Bio/Technology, (19920000), vol. 10, pages 779 - 783
    - THOMPSON et al., J. Mol. Biol., (19960000), vol. 256, pages 359 - 368
    - PATTEN et al., Curr. Opin. Biotechnol., (19970000), vol. 8, pages 724 - 733
    - CRAMERI et al., Nature, (19980000), vol. 391, pages 288 - 291
    - GISH, W.STATES, D.J., Nature Genet., (19930000), vol. 3, pages 266 - 272
    - ALTSCHUL, S.F. et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - MADDEN, T.L. et al., Meth. Enzymol., (19960000), vol. 266, pages 131 - 141
    - ALTSCHUL, S.F. et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - ZHANG, J.MADDEN, T.L., Genome Res., (19970000), vol. 7, pages 649 - 656
    - ANGAL et al., Molecular Immunology, (19930000), vol. 30, pages 105 - 108
    - HARRIS, RJ., Journal of Chromatography, (19950000), vol. 705, pages 129 - 134
    - BERGER CWEBER-BORNHAUSER SEGGENBERGER YHANES JPLUCKTHUN ABOSSHARD H. R., "Antigen recognition by conformational selection", F.E.B.S. Letters, (19990000), vol. 450, doi:10.1016/S0014-5793(99)00458-5, pages 149 - 153, XP004259609

DOI:   http://dx.doi.org/10.1016/S0014-5793(99)00458-5
    - HANES JJERMUTUS LWEBER-BORNHAUSER SBOSSHARD HRPLUCKTHUN A., Proc. Natl. Acad. Sci. U.S.A., (19980000), vol. 95, pages 14130 - 14135
    - ZHAND CSPINELLI SLUGINBUHL BAMSTUTZ PCAMBILLAU CPLUCKTHUN A, "Directed in Vitro Evolution and Crystallographic Analysis of a Peptide-binding Single Chain Antibody Fragment (scFv) with Low Picomolar Affinity", J. Biol. Chem., (20040000), vol. 279, doi:10.1074/jbc.M309169200, pages 18870 - 18877, XP002406477

DOI:   http://dx.doi.org/10.1074/jbc.M309169200
    - CLARGO et al., Mabs, (20140101), vol. 6, no. 1, pages 143 - 159
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.